InflaRx N.V.

IFRX • NASDAQ • Stock Fundamentals

InflaRx N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Niels C. Riedemann, with a market cap of $247.5M.

Market Cap$247.5M

Employees66.0

CEONiels C. Riedemann

CountryGermany

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about InflaRx N.V.

InflaRx N.V. (IFRX) has a market capitalization of $247.5M and trades on NASDAQ.

InflaRx N.V. has approximately 66 employees.